Unexpected Formation of 4-aryl-1-(Propane-2-ylidenehydrazono)-2,3-diazaspiro[5.5]undec-3-ene by the Reaction of Pyridazinethiones Derivatives with Hydrazine
Abstract
1. Introduction
2. Results and Discussion
3. Materials and Methods
3.1. General Information, TLC, Preparative TLC
3.2. NMR Spectroscopy
3.3. Mass Spectrometry
3.4. General Procedure for the Preparation of 1-(Propane-2-ylidenehydrazono)-4-(p-substituted phenyl)-2,3-diazaspiro[5.5]undec-3-ene (3a,3b)
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Inglese, J.; Auld, D.S. Application of High Throughput Screening (HTS) Techniques: Overview of Applications in Chemical Biology. Wiley Encycl. Chem. Biol. 2009, 2, 260–274. [Google Scholar] [CrossRef] [Scilit]
- Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3–25. [Google Scholar] [CrossRef] [Scilit]
- Lipinski, C.A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004, 1, 337–341. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Veber, D.F.; Johnson, S.R.; Cheng, H.-Y.; Smith, B.R.; Ward, K.W.; Kopple, K.D. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002, 45, 2615–2623. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ritchie, T.; Macdonald, S.J. The impact of aromatic ring count on compound developability—are too many aromatic rings a liability in drug design? Drug Discov. Today 2009, 14, 1011–1020. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ritchie, T.J.; Macdonald, S.J.; Young, R.J.; Pickett, S.D. The impact of aromatic ring count on compound developability: Further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. Drug Discov. Today 2011, 16, 164–171. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ritchie, T.J.; Macdonald, S.J.F. Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery. J. Med. Chem. 2014, 57, 7206–7215. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wermuth, C.G. Are pyridazines privileged structures? Med. Chem. Comm. 2011, 2, 935–941. [Google Scholar] [CrossRef] [Scilit]
- Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem. 2009, 52, 6752–6756. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lovering, F. Escape from Flatland 2: Complexity and promiscuity. Med. Chem. Comm. 2013, 4, 515–519. [Google Scholar] [CrossRef] [Scilit]
- Für, C.S.; Riszter, G.; Gerencsér, J.; Szigetvári, Á.; Dékány, M.; Hazai, L.; Keglevich, G.; Bölcskei, H. Synthesis of Spiro[cycloalkane-pyridazinones] with High Fsp3 Character. Lett. Drug Des. Discov. 2020, 17, 731–744. [Google Scholar] [CrossRef] [Scilit]
- Für, C.S.; Horváth, E.J.; Szigetvári, Á.; Dékány, M.; Hazai, L.; Keglevich, G.; Bölcskei, H. Synthesis of Spiro[cycloalkane-pyridazinones] with High Fsp3 Character Part 2*. Lett. Org. Chem. 2021, 18, 373–381. [Google Scholar] [CrossRef] [Scilit]
- Für, C.S.; Bölcskei, H. New Spiro[cycloalkane-pyridazinone] Derivatives with Favorable Fsp3 Character. Chemistry 2020, 2, 837–848. [Google Scholar] [CrossRef] [Scilit]
- Für, C.S.; Riszter, G.; Szigetvári, Á.; Dékány, M.; Keglevich, G.; HazaI, L.; Bölcskei, H. Novel Ring Systems: Spiro[Cycloalkane] Derivatives of Triazolo- and Tetrazolo-Pyridazines. Molecules 2021, 26, 2140. [Google Scholar] [CrossRef] [Scilit]

| Starting Material | R1 | Product | Fsp3 | LogP | ClogP | TPSA |
|---|---|---|---|---|---|---|
| 1a | CH3 | 3a | 0.53 | 4.59 | 5.03 | 49.11 |
| 1b | Cl | 3b | 0.50 | 4.66 | 5.24 | 49.11 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sepsey Für, C.; Keglevich, G.; Bölcskei, H. Unexpected Formation of 4-aryl-1-(Propane-2-ylidenehydrazono)-2,3-diazaspiro[5.5]undec-3-ene by the Reaction of Pyridazinethiones Derivatives with Hydrazine. Molbank 2021, 2021, M1243. https://doi.org/10.3390/M1243
Sepsey Für C, Keglevich G, Bölcskei H. Unexpected Formation of 4-aryl-1-(Propane-2-ylidenehydrazono)-2,3-diazaspiro[5.5]undec-3-ene by the Reaction of Pyridazinethiones Derivatives with Hydrazine. Molbank. 2021; 2021(3):M1243. https://doi.org/10.3390/M1243
Chicago/Turabian StyleSepsey Für, Csilla, György Keglevich, and Hedvig Bölcskei. 2021. "Unexpected Formation of 4-aryl-1-(Propane-2-ylidenehydrazono)-2,3-diazaspiro[5.5]undec-3-ene by the Reaction of Pyridazinethiones Derivatives with Hydrazine" Molbank 2021, no. 3: M1243. https://doi.org/10.3390/M1243
APA StyleSepsey Für, C., Keglevich, G., & Bölcskei, H. (2021). Unexpected Formation of 4-aryl-1-(Propane-2-ylidenehydrazono)-2,3-diazaspiro[5.5]undec-3-ene by the Reaction of Pyridazinethiones Derivatives with Hydrazine. Molbank, 2021(3), M1243. https://doi.org/10.3390/M1243

